Susquehanna Fundamental Investments, LLC Fusion Pharmaceuticals Inc. Transaction History

Susquehanna Fundamental Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$7.97 - $10.66 $200,588 - $268,290	-25,168 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$9.75 - $13.09 $123,600 - $165,941	-12,677 Reduced 33.5%	25,168 $270,000
Q4 2020 Feb 16, 2021	SELL	$11.5 - $13.73 $21,781 - $26,004	-1,894 Reduced 4.77%	37,845 $445,000
Q3 2020 Nov 16, 2020	BUY	$11.8 - $17.1 $468,920 - $679,536	39,739 New	39,739 $478,000

93K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.